Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy

Pramanik R., Sheng X., Ichihara B., Heisterkamp N., Mittelman SD.

Animal Study, published in Leuk Res (2013) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Leuk Res (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23332453
PMCID
PMC3622767
DOI
10.1016/j.leukres.2012.12.013
Citations
78

Abstract (original English)

Obesity is associated with an increased risk of acute lymphoblastic leukemia (ALL) relapse. Using mouse and cell co-culture models, we investigated whether adipose tissue attracts ALL to a protective microenvironment. Syngeneically implanted ALL cells migrated into adipose tissue within ten days. In vitro, murine ALL cells migrated towards adipose tissue explants and 3T3-L1 adipocytes. Human and mouse ALL cells migrated toward adipocyte conditioned media, which was mediated by SDF-1α. In addition, adipose tissue explants protected ALL cells against daunorubicin and vincristine. Our findings suggest that ALL migration into adipose tissue could contribute to drug resistance and potentially relapse.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueCell Line, Tumor3T3-L1 CellsAnimalsHumansMiceVincristineDaunorubicinAntibiotics, AntineoplasticAntineoplastic Agents, Phytogenic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.